JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayorga, A. J.
Right arrow Articles by Lucki, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayorga, A. J.
Right arrow Articles by Lucki, I.

Vol. 298, Issue 3, 1101-1107, September 2001

Antidepressant-Like Behavioral Effects in 5-Hydroxytryptamine1A and 5-Hydroxytryptamine1B Receptor Mutant Mice

Arthur J. Mayorga, Ashutosh Dalvi, Michelle E. Page, Sarah Zimov-Levinson, René Hen and Irwin Lucki

Departments of Psychiatry (A.J.M., A.D., M.E.P., S.V.-L., I.L.) and Pharmacology (I.L.), University of Pennsylvania, Philadelphia, Pennsylvania; and Center for Neurobiology and Behavior, Columbia University, New York, New York (R.H.)

The development of serotonin receptor knockout mice has provided an opportunity to study antidepressant drug effects in animals with targeted genetic deletion of receptors involved in antidepressant responses. In the current study, the effects of two types of antidepressant drugs, the selective serotonin reuptake inhibitors fluoxetine and paroxetine and the selective norepinephrine reuptake inhibitor desipramine, were examined in 5-hydroxytryptamine (5-HT)1A and 5-HT1B receptor mutant mice using the tail suspension test (TST). Under baseline conditions, the immobility of 5-HT1A receptor mutant mice, but not 5-HT1B receptor mutant mice, was significantly lower than that of wild-type mice. The decreased baseline immobility in 5-HT1A receptor mutant mice was reversed by pretreatment with alpha -methyl-para-tyrosine, but not by para-chlorophenylalanine, suggesting mediation by enhanced catecholamine function. In wild-type mice, fluoxetine (10.0-20.0 mg/kg i.p.) and desipramine (5.0-20.0 mg/kg i.p.) both significantly decreased immobility in the TST. In 5-HT1A receptor mutant mice, desipramine (20.0 mg/kg i.p.) significantly decreased immobility, whereas fluoxetine (20.0 mg/kg i.p.) and paroxetine (20.0 mg/kg i.p.) had no effect. The immobility of 5-HT1B receptor mutant mice was decreased similarly by desipramine (5.0-20.0 mg/kg i.p.). However, the effect of low doses of fluoxetine were significantly augmented in the 5-HT1B receptor mutant mice (2.5-20.0 mg/kg i.p.) compared with wild-type mice. Administration of selective 5-HT receptor antagonists in wild-type mice partially reproduced the phenotypes of the mutant mice. These results suggest that 5-HT1A and 5-HT1B receptors have different roles in the modulation of the response to antidepressant drugs in the TST.


0022-3565/01/2983-1101$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
P. Svenningsson, E. T. Tzavara, H. Qi, R. Carruthers, J. M. Witkin, G. G. Nomikos, and P. Greengard
Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6 Receptor Stimulation
J. Neurosci., April 11, 2007; 27(15): 4201 - 4209.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. E. Page, J. F. Cryan, A. Sullivan, A. Dalvi, B. Saucy, D. R. Manning, and I. Lucki
Behavioral and Neurochemical Effects of 5-{4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): A Combined Selective Inhibitor of Serotonin Reuptake and 5-Hydroxytryptamine1A Receptor Partial Agonist
J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1220 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. A. Knobelman, R. Hen, and I. Lucki
Genetic Regulation of Extracellular Serotonin by 5-Hydroxytryptamine1A and 5-Hydroxytryptamine1B Autoreceptors in Different Brain Regions of the Mouse
J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1083 - 1091.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.